DHUNE wants to develop individualised and personalised innovative therapies tailored to each type of patient and environmental context.
DHUNE seeks to optimise drug prescriptions and to evaluate their impact on the daily life of the patient. The Pharmacoepidemiology allows the long-term tracking of large patient groups which enables the exploration of new hypotheses.
In order to better understand the daily troubles of patients, the way they are taken care of and their use of medications, DHUNE has established multiple partnerships with caregivers and patient associations (France Alzheimer, CISS, France Parkinson, PACASEP, UNISEP).
DHUNE is envisaging discoveries on motor skills and cognition, but also on the daily lives of the patients which will enable to form links with the socio-economic world including local incubators and regional businesses as well as supporting structures (SATT, competitiveness clusters).